Corticosteroid-anticholinergic combination

This page covers all Corticosteroid-anticholinergic combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 2 pipeline (1)

• CHF1535 NEXThaler · Chiesi Farmaceutici S.p.A. · Respiratory
  CHF1535 NEXThaler is a dry powder inhaler delivering a fixed dose of a combination of fluticasone furoate and umeclidinium

Patent intelligence

• corticosteroid anticholinergic combination patent landscape — aggregated cliff calendar, attackable patents, originator estates